After a bracket of votes and a flurry of social media debates, #NephMadness 2026 concluded with B-Cell Modulators defeating C3G Treatment for the win, reflecting the growing impact of B-Cell Modulators. Read a recap in #ASNKidneyNews: https://twp.ai/9OXRsK
